| 前收市價 | 3.8500 |
| 開市 | 3.9200 |
| 買盤 | 4.1200 x 100 |
| 賣出價 | 4.1300 x 100 |
| 今日波幅 | 3.9200 - 4.1950 |
| 52 週波幅 | 3.6200 - 8.0500 |
| 成交量 | |
| 平均成交量 | 1,372,490 |
| 市值 | 1.214B |
| Beta 值 (5 年，每月) | 0.36 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.5100 |
| 業績公佈日 | 2024年5月07日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 15.38 |
ZacksCytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Cytokinetics (CYTK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksAnalysts Estimate AbCellera Biologics Inc. (ABCL) to Report a Decline in Earnings: What to Look Out for
AbCellera Biologics (ABCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
InvestorPlaceThe 7 Best Penny Stocks to Buy in Q2 2024
This month in March is a great time to pick up shares in these best penny stocks to buy. I chose the companies due to their strong fundamentals and potential for significant upside. Investing in penny stocks can provide the opportunity for substantial returns, as these lower-priced shares have more room for capital appreciation compared to large-cap stocks. However, penny stocks also come with increased volatility and risk, so it’s important to thoroughly research each company. With major indice
